Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: An overview

Chinese Medical Journal

Volumn 117, Issue 2, 2004, Pages 291-295

  Şimşek, Bariş ^a,b   Karacaer, Özgül ^a   Karaca, Inci ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Biochemical markers; Bone resorption marker; C telopeptides; Collagen breakdown; Deoxypyrolidine; Hydroxylysine glycosides; Hydroxyproline; N telopeptides; Pyrolidine

Indexed keywords

AMINO ACID; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; HYDROXYLYSINE; HYDROXYPROLINE; PYRIDINIUM DERIVATIVE;

BONE DEFECT; BONE METABOLISM; COLLAGEN DEGRADATION; CROSS LINKING; EARLY DIAGNOSIS; HUMAN; HYDROXYPROLINE URINE LEVEL; MEASUREMENT; MEDICAL RESEARCH; METABOLIC BONE DISEASE; OSTEOCLAST; OSTEOLYSIS; PUBLICATION; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; BONE RESORPTION; COLLAGEN; HUMANS; HYDROXYLYSINE; HYDROXYPROLINE; PYRIDINIUM COMPOUNDS;

EID: 17144446565     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Christenson RH. Biochemical markers of bone metabolism: An overview. Clin Biochem 1997;30:573-593.
2. Guise TA. Parathyroid hormone-related protein and bone metastases. Cancer 1997;80:1572-1580.
3. Delmas PD. What do we know about biochemical bone markers? Baillieres Clin Obstet Gynaecol 1991;5:817-830.
4. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8(Suppl 2):S549-S555.
5. Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999;45:1359-1368.
6. Deftos LJ. Bone protein and peptide assays in the diagnosis and management of skeletal disease. Clin Chem 1991;37: 1143-1148.
7. Karaca i, Ugar DA. What do we know about serum alkaline phosphatase activity as a biochemical bone formation marker? Biochem Archi 1999;15:1-4.
8. Ugar DA, Karaca i. Serum osteocalcin as a biochemical bone formation marker. Biochem Archi 1999;15:379-382.
9. Demers LM. Clinical usefulness of markers of bone degradation and formation. Scand J Clin Lab Invest 1997;57 (Suppl 227):S12-S20.
10. Bonde M, Qvist P, Flededius C, et al. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow up on hormone replacement therapy an osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80:864-868.
11. Garnero P, Hausherr E, Chapuy M. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 1996;11:1531-1537.
12. Demers LM, Costa L, Lipton A. Biochemical markers and skeletal metastases. Cancer 2000;88:2919-2926.
13. Garnero P, Delmas PD. Bone markers. Baillieres Clin Rheumatol 1997;11:517-537.
14. 1-galactosyl-O-hydroxylysine (GH) as a marker of collagen turnover of bone. Calcif Tissue 1988;42:87-90.
15. Shapses SA, Weissman C, Seibel J, et al. Urinary pyridinium cross-link excretion is increased in critically ill surgical patients. Critical Care Med 1997;25:85-90.
16. Eyre DR, Koob TJ, Van Ness KP. Quantiation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal Biochem 1984;137:380-388.
17. Fontana A, Delmas PD. Markers of bone turnover in bone metastasis. Cancer 2000;88:2952-2960.
18. Eyre DR, Dickson IR, Van Ness KP. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypridinium residues. Biochem J 1988;252:495-500.
19. Colwell A, Eastell R. The renal clearence of free and conjugated pyridinium crosslinks of collagen. J Bone Miner Res 1996;11:1976-1980.
20. Marowska J, Kobylinska M, Lukaszkiewicz J, et al. Pyridium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: Normal values and clinical application. Bone 1996;19:669-677.
21. Sinigaglia L, Varenna M, Binelli L, et al. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone. Calcif Tissue Int 1997;61:279-284.
22. Demers LM. Recent advantages in biochemical markers of bone turnover, Clin Chem 1994;40:1994-1995.
23. Toori KU, Bone MF, Labib MH. Raised urinary pyridium cross-links in humoral hypercalcaemia of malignancy. Ann Clin Biochem 1999;36:107-108.
24. Clemens JD, Herrick MV, Singer FR, et al. Evidence that serum NTx (collagen- type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 1997; 43:2058-2063.
25. Prockop OJ, Kivirikko KI. Hydroxyproline and the metabolism of collagen. In: B. S. Gould, ed. Treatise on metabolism of collagen. New York: Academic Press; 1987: 215-246.
26. Prockop OJ, Kivirikko KI, Tuderman K, et al. The biosynthesis of collagen and its disorders. New Engl J Med 1979;301:13-23.
27. Kivirikko KI. Excretion of urinary hydroxyproline peptide in the assessment of bone collagen deposition and resorption. In: B. Frame JT, Jr Potts, ed. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica; 1983: 105-107.
28. Lowry M, Hall DE, Brosnan JJ. Hydroxyproline metabolism in the rat kidney distrubition of the renal enzimes of hydroxyproline catabolism and renal conversion of hydroxyproline to glycine and serine. Metabolism 1985;34: 955-961.
29. Kanis JA, Mc Closkey EV. Bone turnover and biochemical markers in malignancy. Cancer 1997;80:1538-1545.
30. Deacon AC, Hulme P, Hesp R, et al. Estimation of whole body bone resorption rate: A comperison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Chim Acta 1987;166:297-306.
31. Beardsworth LJ, Eyre DR, Dickson IR. Chances with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Min Res 1990;5:671-676.
32. Krane SM, Kantrowitz FG, Byrne M, et al. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J Clin Invest 1977;59:819-827.
33. Kleerekoper M, Edelson GW. Biochemical studies in the evaluation and management of osteoporosis: Current status and future prospects. Endocrin Pract 1996;2:13-19.
34. Wilson PS, Kleerekoper M, Bone H, et al. Urinary total hydroxyproline measured by HPLC: Comparison of spot and timed urine collections. Clin Chem 1990;36:388-389.
35. Percival RC, Urwin GH, Harris S, et al. Biochemical and histologic evidence that carcinoma of the prostate is associated with increased bone resorption. Eur J Surg Oncol 1987;13: 41-49.
36. Urwin GH, Percival RC, Yates AJP, et al. Biochemical markers and skeletal metabolism in carcinoma of the prostate. Use of descision matrix theraphy and ROC analysis. Br J Urol 1985;57:711-714.
37. Kleerekoper M, Avioli L. Evaluation and treatment of postmenopausal osteoporosis. In: M. J. FAVUS, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 2nd. New York: Raven Press; 1993:223-229.
38. Hyldstrup L, McNair P, Jensen GF, et al. Bone mass as referent for urinary hydroxyproline excretion: Age and sex-related chances in 125 normals and in primary hyperparathyroidism. Calcif Tissue Int 1984;36:639-644.
39. Kunimatsu K, Mataki S, Tanaka H, et al. A cross-sectional study on osteocalcin levels in gingival creviculer fluid from periodontal patients. J Periodontol 1993;64:865-869.
40. Ralls SA, Cohen ME. Problems in identifying bursts of periodontal attachement loss. J Periodontol 1986;57:746-752.
41. Benn DK. A review of the reability of radiographic measurements in estimating alveolar bone changes. J Clin Periodontol 1990;17:14-21.
42. Akalin FA, Sengun D, Eratalay K, et al. Hydroxyproline and total protein levels in gingiva and gingival creviculer fluid in patients with juvenile, rapidly progressive, and adult periodotitis. J Periodontol 1993;64:323-329.
43. Narayanan AS, Page RC, Demers DF. Characterization of collagens of diseased human gingival. Biochemistry 1980;19: 5037-5043.
44. Narayanan AS, Page RC, Kuzan F. Collagens synthesized in vitro by diploid fibroblasts obtained from chronically inflamed human connective tissue. Lab Invest 1978;39:61-65.
45. Stimler NP. High-performance liquid chomatographic quantitation of collagen biosynthesis in explant cultures. Anal Biochem 1984;142:103-108.
46. Svanberg GK. Hydroxyproline determination in serum and gingival crevicular fluid. J Periodont Res 1987;22:133-138.
47. Hara K, Takahashi T. Hydroxyproline content in gingival exudate before and after periodontal surgery. J Periodont Res 1975;10:270-274.
48. Svanberg GK. Hydroxyproline titers in gingival crevicular fluid. J Periodont Res 1987;22:212-214.
49. Turpeinen U, Pomoell UM. Liquid chromatography of free hydroxyproline in serum. Clin Chem 1985;31:1710-1712.
50. Percival RC, Yates AJP, Gray RES, et al. Mechanisms of malignant hypercalcaemia in carcinoma of the breast. BMJ 1985;291:776-779.
51. Deftos LJ, Glowacki J. Mechanisms of bone metabolism. In: D. C. Kem, E. Frohlich, ed. Pathophysiology. 3rd. Philadelphia: J. B. Lippincott Co.; 1984:445-468.